ITRACONAZOLE

• Category :

  Intermediates/Pharmaceutical intermediates

• Synonyms :

  2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl methyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one;oriconazole;sporanox;itraconozole;

• CAS NO :

  84625-61-6

• EC NO :

• Molecular Formula :

  C₃₅H₃₈Cl₂N₈O₄

• Molecular Weight :

  705.63

• Main Specifications :

  W hite or yellowish white powder

• InChI :

  InChI=1/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1

• Packing :

  25kg/Drum

• Product description :

  CAS NO	84625-61-6	Cate	Pharmaceutical Material
  Product Name	Itraconazole
  molecular formula	C35H38Cl2N8O4	Molecular Weigh	705.64
  Structural Formula
  Standard	BP2000/EP2000	Package	25kg/Drum
  Specification	Appearance:W hite or yellowish white powder Melting point: 166-170 oC Assay: 98.5%-101.5% Loss on drying :≤0.5%
  Usage	This product is antifungus with three azole rings. It has antibiotic function both to deep and surface fungus. In clinical Practice,it is mainly used in the treatment of systems infection Caused by deep fungi and candida.
  Other Information

• Uses :

  This product is synthetic azoles antifongin with three azole rings. It has antibiotic fuction both to deep surface fungus. In clinical Practice,it is mainly used in the treatment of systems infection Caused by deep fungus.

• Molecular Structure :